Education
About Us
Working with TipRanks
Follow Us
EKG - ETF AI Analysis
Top Page
First Trust Nasdaq Lux Digital Health Solutions ETF (EKG)
Rating:70Outperform
Price Target:―
Positive Factors
Improving Recent Performance
The ETF has shown steady gains over the past three months and year to date, suggesting positive recent momentum.
Several Strong Top Holdings
Many of the largest positions, such as IQVIA, Dexcom, Resmed, Guardant Health, Illumina, Natera, and Align Technology, have delivered strong year-to-date results that support the fund’s overall performance.
Focused Digital Health Theme
The fund targets digital health companies, giving investors concentrated exposure to a growing area within health care.
Negative Factors
High Sector Concentration
Almost all assets are in the health care sector, so the ETF is heavily exposed to swings in that single industry.
Limited Geographic Diversification
With nearly all holdings in U.S. companies, the fund offers little protection if the U.S. market or economy weakens.
Relatively High Expense Ratio
The ETF’s fee is on the higher side for an index-based product, which can modestly reduce long-term returns for investors.
EKG vs. SPDR S&P 500 ETF (SPY)
AUM2.68M
RegionGlobal
Expense Ratio0.65%
Beta0.96
IssuerFirst Trust
Inception DateMar 22, 2022
Dividend YieldN/A
Asset ClassEquity
Index TrackedNASDAQ Lux Health Tech Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume320
30 Day Avg. Volume833
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
22.78Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering36
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
EKG Summary
EKG is an ETF that follows the NASDAQ Lux Health Tech Index, focusing on digital health companies that use technology to improve medical care. It holds firms involved in tools like remote monitoring, medical devices, and health software. Well-known holdings include Intuitive Surgical, which makes robotic surgery systems, and Dexcom, known for continuous glucose monitors. Someone might invest in EKG to tap into the long-term growth of technology in health care and to get a basket of these companies in one fund. A key risk is that it is heavily concentrated in health tech, so its price can swing more than the overall market.
How much will it cost me?The First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) has an expense ratio of 0.65%, which means you’ll pay $6.50 per year for every $1,000 invested. This is higher than average because it is actively managed, focusing on a niche sector like digital health that requires specialized research and expertise.
What would affect this ETF?The EKG ETF, focused on digital health innovations, could benefit from growing demand for telemedicine, wearable health devices, and AI-driven diagnostics as health care increasingly integrates technology. However, it may face challenges from regulatory changes in health care, economic downturns affecting consumer spending on health tech, or competition within the sector. Its global exposure and top holdings in companies like IQVIA and Veeva Systems position it well for growth but also make it sensitive to international market conditions.
EKG Top 10 Holdings
EKG is a pure play on digital health, with nearly all its firepower in health care technology names across a global mix. IQVIA and Dexcom are among the key engines, rising on solid growth and enthusiasm around data and AI in medicine. Illumina, Guardant Health, and Align Tech are also adding fuel with strong recent momentum. On the flip side, Intuitive Surgical looks a bit tired after a mixed stretch, and Veeva Systems has been lagging, acting as a small brake on an otherwise forward‑moving portfolio.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Intuitive Surgical | 9.40% | $250.51K | $177.84B | -14.83% | 78 Outperform | |
| Dexcom | 8.57% | $228.30K | $28.02B | -17.68% | 79 Outperform | |
| Resmed | 8.33% | $222.07K | $37.72B | 11.84% | 76 Outperform | |
| IQVIA Holdings | 7.66% | $204.21K | $29.03B | -13.31% | 73 Outperform | |
| Guardant Health | 6.31% | $168.05K | $13.90B | 140.49% | 61 Neutral | |
| Veeva Systems | 5.91% | $157.59K | $29.79B | -20.14% | 66 Neutral | |
| Align Tech | 5.91% | $157.53K | $13.69B | -0.22% | 74 Outperform | |
| Natera | 5.56% | $148.27K | $29.81B | 30.69% | 73 Outperform | |
| Illumina | 5.20% | $138.50K | $18.36B | 24.92% | 71 Outperform | |
| Globus Medical | 4.89% | $130.18K | $12.13B | 12.84% | 82 Outperform |
EKG Technical Analysis
Negative
―
Price Trends
18.99
Negative
18.73
Negative
18.01
Negative
Market Momentum
-0.44
Positive
37.75
Neutral
81.22
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For EKG, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 18.32, equal to the 50-day MA of 18.99, and equal to the 200-day MA of 18.01, indicating a bearish trend. The MACD of -0.44 indicates Positive momentum. The RSI at 37.75 is Neutral, neither overbought nor oversold. The STOCH value of 81.22 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for EKG.
EKG Peer Comparison
Comparison Results
Performance Comparison
EKG
First Trust Nasdaq Lux Digital Health Solutions ETF
17.76
-0.24
-1.33%
FMED
Fidelity Disruptive Medicine ETF
―
―
―
OZEM
Roundhill GLP-1 & Weight Loss ETF
―
―
―
HRTS
Tema Cardiovascular and Metabolic ETF
―
―
―
HTEC
ROBO Global Healthcare Technology and Innovation ETF
―
―
―
HEAL
Global X HealthTech ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents